79 related articles for article (PubMed ID: 2005461)
1. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
2. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
3. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
5. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
7. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.
Strømhaug PE; Berg TO; Gjøen T; Seglen PO
Eur J Cell Biol; 1997 May; 73(1):28-39. PubMed ID: 9174669
[TBL] [Abstract][Full Text] [Related]
8. Effect of protein binding on renal extraction of 131I-OIH and 99mTc-labeled tubular agents.
Eshima D; Eshima L; Hansen L; Lipowska M; Marzilli LG; Taylor A
J Nucl Med; 2000 Dec; 41(12):2077-82. PubMed ID: 11138695
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-neolactosylated human serum albumin for imaging the hepatic asialoglycoprotein receptor.
Jeong JM; Hong MK; Lee J; Son M; So Y; Lee DS; Chung JK; Lee MC
Bioconjug Chem; 2004; 15(4):850-5. PubMed ID: 15264873
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholestasis on hepatic transport of 99mtechnetium p-isopropyl-iminodiacetic acid.
Knodell RG; Shafer RB; Stanley LN; Goodman M; Elson MK
J Lab Clin Med; 1984 Oct; 104(4):517-27. PubMed ID: 6481215
[TBL] [Abstract][Full Text] [Related]
12. Effects of monensin on vesicular transport pathways in the perfused rat liver.
Kloppel TM; Brown WR; Reichen J
J Cell Biochem; 1986; 32(3):235-45. PubMed ID: 3782315
[TBL] [Abstract][Full Text] [Related]
13. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin G, F(AB')2, and fab fragment uptake kinetics in isolated perfused rat liver and rat hepatic cells.
Bazin-Redureau M; Gires P; Chapelle P; Martinet M; Scherrmann JM
Drug Metab Dispos; 1995 Dec; 23(12):1400-6. PubMed ID: 8689951
[TBL] [Abstract][Full Text] [Related]
15. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver.
de Jong M; Bakker WH; Breeman WA; van der Pluijm ME; Kooij PP; Visser TJ; Docter R; Krenning EP
J Nucl Med; 1993 Nov; 34(11):2025-30. PubMed ID: 8229254
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results.
Leitha T; Staudenherz A; Gmeiner B; Hermann M; Hüttinger M; Dudczak R
Eur J Nucl Med; 1993 Aug; 20(8):674-9. PubMed ID: 8404953
[TBL] [Abstract][Full Text] [Related]
19. Dissection of hepatic receptor-mediated endocytic pathways using self-generated gradients of iodixanol (Optiprep).
Billington D; Maltby PJ; Jackson AP; Graham JM
Anal Biochem; 1998 May; 258(2):251-8. PubMed ID: 9570838
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-labeled medium-chain fatty acid analogues metabolized by beta-oxidation: radiopharmaceutical for assessing liver function.
Yamamura N; Magata Y; Arano Y; Kawaguchi T; Ogawa K; Konishi J; Saji H
Bioconjug Chem; 1999; 10(3):489-95. PubMed ID: 10346882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
